彭金昀, 唐运莲, 何洁, 张杨, 彭娟, 贺荣芳, 甘润良. 不同部位和类型恶性淋巴瘤与EBV感染相关性研究[J]. 中国肿瘤临床, 2008, 35(20): 1145-1149.
引用本文: 彭金昀, 唐运莲, 何洁, 张杨, 彭娟, 贺荣芳, 甘润良. 不同部位和类型恶性淋巴瘤与EBV感染相关性研究[J]. 中国肿瘤临床, 2008, 35(20): 1145-1149.
PENG Jin-yun, TANG Yun-lian, HE Jie, ZHANG Yang, PENG Juan, HE Rong-fang, GAN Run-liang. The Prevalence of EBV Infection in Lymphomas of Different Type or in Different Sites[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2008, 35(20): 1145-1149.
Citation: PENG Jin-yun, TANG Yun-lian, HE Jie, ZHANG Yang, PENG Juan, HE Rong-fang, GAN Run-liang. The Prevalence of EBV Infection in Lymphomas of Different Type or in Different Sites[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2008, 35(20): 1145-1149.

不同部位和类型恶性淋巴瘤与EBV感染相关性研究

The Prevalence of EBV Infection in Lymphomas of Different Type or in Different Sites

  • 摘要: 目的: 对不同部位和类型的恶性淋巴瘤中EB病毒(Epstein-Barr virus,EBV)的感染情况进行检测和分析,探讨EBV感染可能与恶性淋巴瘤的病因关系。 方法: 收集恶性淋巴瘤组织标本127例,其中鼻腔及鼻咽淋巴瘤60例,胃淋巴瘤30例,表浅淋巴结淋巴瘤37例。组织病理学诊断为非霍奇金淋巴瘤(NHL)108例,霍奇金淋巴瘤(HD)19例。采用原位分子杂交方法检测淋巴瘤组织中EBV编码的小RNA(EBER),确定EBV在恶性淋巴瘤细胞中的存在。 结果: 108例NHL(包括鼻腔及鼻咽、胃、表浅淋巴结部位),EBER检测46例阳性,阳性率为42.6%。鼻腔/鼻咽NHL的EBER阳性率为58.3%(35/60),其中NK/T细胞淋巴瘤29例,EBER阳性19例,阳性率为65.5%(19/29);B细胞淋巴瘤31例,EBER阳性16例,阳性率为51.6%(16/31)。胃部NHL的EBER阳性率为30.0%(9/30),其中B细胞淋巴瘤28例,EBER阳性9例,阳性率为32.1%(9/28);T细胞淋巴瘤2例,均为EBER阴性。表浅淋巴结NHL18例,EBER阳性2例,阳性率为11.1%(2/18);表浅淋巴结HD19例,EBER阳性5例,阳性率为26.3%(5/19)。 结论: 本组资料非霍奇金淋巴瘤EBV感染阳性率(42.6%)略高于霍奇金淋巴瘤EBV感染阳性率(26.3%),差异无显著性意义(P>0.05)。鼻腔及鼻咽NHL的EBV感染阳性率(58.3%)高于胃NHL(30.0%)和表浅淋巴结NHL(11.1%)(P<0.05)。研究提示各类型淋巴瘤与EBV感染均有密切关系,且存在部位依赖性。

     

    Abstract: Objective : Epstein-Barr virus (EBV) is a DNA virus related to some human malignancies. The aim of thisstudy was to investigate the association of EBV infection with malignant lymphomas of different type or in dif-ferent anatomical sites. Methods : We analyzed 127 tissue samples of malignant lymphomas including 60 lym-phomas in the nasal cavity and nasopharynx, 30 lymphomas in the stomach and 37 lymphomas in superficiallymphnodes. There were 19 cases of Hodgkin's disease (HD) and 108 cases of non-Hodgkin's lymphoma(NHL). According to immunohistochemical features, all of the 108 non-Hodgkin's lymphomas were divided intothree immunophenotypes: B-cell lymphoma, T-cell lymphoma, and NK/T-cell lymphoma based on their differ-ent immune markers of CD20, CD79a, CD45RO, CD3 and CD56. In situ hybridization was employed to detectthe EBV-encoded small RNA (EBER) in tumor cells. Results : There were 46 EBER positive cases in all of the108 cases of NHL. The positive rate of EBER in NHL cases was 42.6%. The positive rate of NHL in the nasalcavity and nasopharynx was 58.3% (35/60 cases). There were 29 cases of NK/T-cell lymphoma, 19 of whichwere EBER positive. The EBER-positive rate in NK/T-cell lymphomas was 65.5% (19/29 cases). There were31 cases of B-cell lymphoma, including 16 EBER positive cases. The EBER-positive rate of B-cell lymphomain the nasal cavity and nasopharynx was 51.6% (16/31 cases). The EBER-positive rate of primary gastric NHLwas 30% (9/30 cases). There were 28 cases of gastric B-cell lymphomas, including 9 EBER positive cases.The EBER positive rate of gastric B-cell lymphomas was 32.1% (9/28 cases). There were 2 cases of gastric T-cell lymphoma, which were EBER negative. The EBER positive rate of NHL in superficial lymph nodes was11.1% (2/18 cases), including one EBER positive case in 8 cases of T-cell lymphomas and one EBER positivecase in 10 cases of B-cell lymphomas. The EBER positive rate in HD of superficial lymph nodes was 26.3%(5/19 cases). EBV infection rate was a little higher in patients with NHL (42.6%) than in patients with HD(26.3%), but with no significant difference (P>0.05). The EBER positive rate in NHL of the nasal cavity and na-sopharynx was higher than in NHL of the stomach and superficial lymp hnodes (P<0.05). Conclusion : Differenttypes of human lymphomas are strongly associated with EBV infection. The EBV positive rate is related withthe site of lymphoma.

     

/

返回文章
返回